Point of Care Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The POC Molecular Diagnostics Market is Segmented by Application (Infectious Diseases, Oncology, Haematology, Prenatal Testing, Endocrinology, and Other Applications), Technology (PCR, Genetic Sequencing, Hybridization, and Microarray), End User (Hospitals, Homecare, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Point of Care Molecular Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Point of Care Molecular Diagnostics Industry Overview

The point-of-care molecular diagnostics market is consolidated. Global key players develop the majority of point-of-care molecular diagnostic tests. Market leaders with more funds for research and a better distribution system have established their position in the market. Moreover, Asia-Pacific is witnessing the emergence of some small players due to the growing awareness, which has also helped the market to grow. Some of the major players include Abbott Laboratories, Bayer AG, Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Danaher Corporation, and BioMerieux.

Point of Care Molecular Diagnostics Market Leaders

  1. Abbott Laboratories

  2. Danaher Corporation

  3. BioMerieux

  4. Bio-Rad Laboratories

  5. F. Hoffmann-La Roche Ltd

  6. *Disclaimer: Major Players sorted in no particular order
"Abbott Laboratories, F. Hoffmann-La Roche Ltd., Danaher Corporation, BioMerieux, Bio-Rad Laboratories"

Point of Care Molecular Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?